SPARC ectopic overexpression inhibits growth and promotes programmed cell death in acute myeloid leukemia transformed from myelodysplastic syndrome cells, alone and in combination with Ara-C treatment

  • Authors:
    • Qing Nian
    • Jianxiang Chi
    • Qing Xiao
    • Chunmei Wei
    • Paul Costeas
    • Zesong Yang
    • Lin Liu
    • Li Wang
  • View Affiliations

  • Published online on: July 8, 2015     https://doi.org/10.3892/or.2015.4114
  • Pages: 1406-1414
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Secreted protein acidic and rich in cysteine (SPARC) has a complex and pleiotropic biological role in cell life during disease. The role of SPARC in myelodysplastic syndrome (MDS) is not yet fully understood. In the present study, we investigated the role of SPARC protein overproduction in the proliferation and apoptosis of SKM-1 cells, an acute myeloid leukemia cell line transformed from MDS. SKM-1 cells were infected with the pGC-GV-SPARC vector. The cells were then assessed for proliferation and cell death following treatment with low-dose cytosine arabinoside (Ara‑C). The microarray analysis results revealed that samples from SPARC‑overexpressed cells compared to SPARC protein, in SKM-1 cells led to proliferation inhibition and promoted programmed cell death and these effects were greater when treated with Ara-C. The mRNA and protein expression levels of SPARC were detected by SPARC overexpression in cells treated with Ara-C resulting in a significant upregulation of the mixed lineage kinase domain-like (MLKL) gene expression and five other genes. The results showed that the necrotic signaling pathway may play a role when the two conditions were combined via the upregulation of the MLKL protein. MLKL upregulation in SPARC overexpressed cells treated with Ara-C, indicates necrosis as a possible cell death process for the SKM-1 cells under these stringent conditions.

Related Articles

Journal Cover

September-2015
Volume 34 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nian Q, Chi J, Xiao Q, Wei C, Costeas P, Yang Z, Liu L and Wang L: SPARC ectopic overexpression inhibits growth and promotes programmed cell death in acute myeloid leukemia transformed from myelodysplastic syndrome cells, alone and in combination with Ara-C treatment. Oncol Rep 34: 1406-1414, 2015
APA
Nian, Q., Chi, J., Xiao, Q., Wei, C., Costeas, P., Yang, Z. ... Wang, L. (2015). SPARC ectopic overexpression inhibits growth and promotes programmed cell death in acute myeloid leukemia transformed from myelodysplastic syndrome cells, alone and in combination with Ara-C treatment. Oncology Reports, 34, 1406-1414. https://doi.org/10.3892/or.2015.4114
MLA
Nian, Q., Chi, J., Xiao, Q., Wei, C., Costeas, P., Yang, Z., Liu, L., Wang, L."SPARC ectopic overexpression inhibits growth and promotes programmed cell death in acute myeloid leukemia transformed from myelodysplastic syndrome cells, alone and in combination with Ara-C treatment". Oncology Reports 34.3 (2015): 1406-1414.
Chicago
Nian, Q., Chi, J., Xiao, Q., Wei, C., Costeas, P., Yang, Z., Liu, L., Wang, L."SPARC ectopic overexpression inhibits growth and promotes programmed cell death in acute myeloid leukemia transformed from myelodysplastic syndrome cells, alone and in combination with Ara-C treatment". Oncology Reports 34, no. 3 (2015): 1406-1414. https://doi.org/10.3892/or.2015.4114